GUZMAN, A. Topical Cantharidin Revisited: A Phase 2 Study Investigating a Commercially-Viable Formulation of Cantharidin (VP-102) for the Treatment of Molluscum Contagiosum. SKIN The Journal of Cutaneous Medicine, v. 2, p. S103-S104, 17 Dec. 2018.